BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 29768112)

  • 1. "Marvin, the Paranoid Android": The Case of an Alpha-PVP User in the Expanding Galaxy of NPS.
    Pierluigi S; Laura B; Attilio N; Gurjeet K B; Gloria P; Davide M; Borgherini G; Giovanni M; Fabrizio S; Perini G; Ornella C
    J Psychoactive Drugs; 2018; 50(4):306-313. PubMed ID: 29768112
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reinforcing and discriminative-stimulus effects of two pyrrolidine-containing synthetic cathinone derivatives in rats.
    Xu P; Lai M; Fu D; Liu H; Wang Y; Shen H; Zhou W
    Pharmacol Biochem Behav; 2021 Apr; 203():173128. PubMed ID: 33515585
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alpha-PVP induces the rewarding effect via activating dopaminergic neuron.
    Hataoka K; Kaizaki-Mitsumoto A; Numazawa S
    J Toxicol Sci; 2017; 42(5):539-543. PubMed ID: 28904288
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MDPV and α-PVP use in humans: The twisted sisters.
    Karila L; Lafaye G; Scocard A; Cottencin O; Benyamina A
    Neuropharmacology; 2018 May; 134(Pt A):65-72. PubMed ID: 29030166
    [TBL] [Abstract][Full Text] [Related]  

  • 5. α-Pyrrolidinopentiophenone ("Flakka") Catalyzing Catatonia: A Case Report and Literature Review.
    Richman EE; Skoller NJ; Fokum B; Burke BA; Hickerson CA; Cotes RO
    J Addict Med; 2018; 12(4):336-338. PubMed ID: 29533309
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DARK Classics in Chemical Neuroscience: α-Pyrrolidinovalerophenone ("Flakka").
    Kolesnikova TO; Khatsko SL; Demin KA; Shevyrin VA; Kalueff AV
    ACS Chem Neurosci; 2019 Jan; 10(1):168-174. PubMed ID: 30384587
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Explosion of a New Designer Drug, Flakka: Implications for Practice.
    J Addict Nurs; 2018; 29(4):E16-E17. PubMed ID: 30507827
    [No Abstract]   [Full Text] [Related]  

  • 8. Naphyrone: a "legal high" not legal any more.
    Vardakou I; Pistos C; Dona A; Spiliopoulou C; Athanaselis S
    Drug Chem Toxicol; 2012 Oct; 35(4):467-71. PubMed ID: 22168347
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Cathinones MDPV and α-PVP Elicit Different Behavioral and Molecular Effects Following Acute Exposure.
    Giannotti G; Canazza I; Caffino L; Bilel S; Ossato A; Fumagalli F; Marti M
    Neurotox Res; 2017 Nov; 32(4):594-602. PubMed ID: 28646469
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The synthetic cathinone α-pyrrolidinovalerophenone (α-PVP): pharmacokinetic and pharmacodynamic clinical and forensic aspects.
    Nóbrega L; Dinis-Oliveira RJ
    Drug Metab Rev; 2018 May; 50(2):125-139. PubMed ID: 29540067
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacological effects of methamphetamine and alpha-PVP vapor and injection.
    Marusich JA; Lefever TW; Blough BE; Thomas BF; Wiley JL
    Neurotoxicology; 2016 Jul; 55():83-91. PubMed ID: 27237056
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Behavioral Effects of 4-CMC and 4-MeO-PVP in DBA/2J Mice After Acute and Intermittent Administration and Following Withdrawal from Intermittent 14-Day Treatment.
    Wojcieszak J; Kuczyńska K; Zawilska JB
    Neurotox Res; 2021 Jun; 39(3):575-587. PubMed ID: 33428180
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuropsychopharmacology of Emerging Drugs of Abuse:
    Nadal-Gratacós N; Lleixà E; Gibert-Serramià M; Estrada-Tejedor R; Berzosa X; Batllori X; Pubill D; Camarasa J; Escubedo E; López-Arnau R
    Int J Mol Sci; 2022 Feb; 23(4):. PubMed ID: 35216339
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Flakka: New Dangerous Synthetic Cathinone on the Drug Scene.
    Patocka J; Zhao B; Wu W; Klimova B; Valis M; Nepovimova E; Kuca K
    Int J Mol Sci; 2020 Oct; 21(21):. PubMed ID: 33142953
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Toxicity evaluation of α-pyrrolidinovalerophenone (α-PVP): results from intoxication cases within the STRIDA project.
    Beck O; Franzén L; Bäckberg M; Signell P; Helander A
    Clin Toxicol (Phila); 2016 Aug; 54(7):568-75. PubMed ID: 27412885
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Are "bath salts" the next generation of stimulant abuse?
    Winder GS; Stern N; Hosanagar A
    J Subst Abuse Treat; 2013 Jan; 44(1):42-5. PubMed ID: 22445773
    [TBL] [Abstract][Full Text] [Related]  

  • 17. When fish take a bath: Psychopharmacological characterization of the effects of a synthetic cathinone bath salt 'flakka' on adult zebrafish.
    Kolesnikova TO; Khatsko SL; Eltsov OS; Shevyrin VA; Kalueff AV
    Neurotoxicol Teratol; 2019; 73():15-21. PubMed ID: 30796953
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of synthetic cathinone naphyrone in the conditioned place preference test - Evidence of its addictive potential.
    Danda H; Pinterová-Leca N; Šíchová K; Štefková-Mazochová K; Syrová K; Olejníková L; Končická M; Mazoch V; Lhotková E; Kuchař M; Páleníček T
    Behav Brain Res; 2022 Mar; 421():113713. PubMed ID: 34906607
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New recreational drug 1-phenyl-2-(1-pyrrolidinyl)-1-pentanone (alpha-PVP) activates central nervous system via dopaminergic neuron.
    Kaizaki A; Tanaka S; Numazawa S
    J Toxicol Sci; 2014 Feb; 39(1):1-6. PubMed ID: 24418703
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Four Synthetic Cathinones: 3-Chloromethcathinone, 4-Chloromethcathinone, 4-Fluoro-α-Pyrrolidinopentiophenone, and 4-Methoxy-α-Pyrrolidinopentiophenone Produce Changes in the Spontaneous Locomotor Activity and Motor Performance in Mice with Varied Profiles.
    Wojcieszak J; Kuczyńska K; Zawilska JB
    Neurotox Res; 2020 Aug; 38(2):536-551. PubMed ID: 32506339
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.